LENSAR, Inc. (LNSR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US52634L1089
LENSAR, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 58.44 m USD |
| Gross profit | 27.12 m USD |
| Operating income | -24.58 m USD |
| EBIT | -34.28 m USD |
| Net income | -34.28 m USD |
| Diluted EPS – continuing operations | -2.87 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
More stocks
- Mercuries F&B Co., Ltd. (7705.TW)
- Pyxis Tankers Inc (PXS)
- United Radiant Technology (5315.TWO)
- GO Element Co. Ltd. (311320.KQ)
- Drb Holding (004840.KS)
- NRB Inc. (475230.KQ)
- Ta Yih Industrial Co Ltd (1521.TW)
- Osteonic Co. Ltd (226400.KQ)
- Hotron Precision Electronic Industrial Co Ltd (3092.TW)
- PT Trimitra Trans Persada Tbk (BLOG.JK)
- HRS Co. Ltd (036640.KQ)
- Justek, Inc. (153890.KQ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.